Over the years, there has been repeated acknowledgement that the 340B program is often not supporting the patients it was intended to help. (If you need a reminder, check out this piece in the New England Journal of Medicine or this Government Accountability Office report or even this new piece in the American Journal of Managed Care.) Despite this evidence, some advocates claim contract pharmacy participation in the 340B program is helping patients access medicines. The truth is, there are zero 340B protections in place to ensure that needy patients get discounted medicines from contract pharmacies. Let’s look at the facts.
